Detailed results from pivotal TALAPRO-3 study presented at ASCO 2026 and published in The New England Journal of Medicine TALZENNA plus XTANDI demonstrated a 52% reduction in the risk of radiographic ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test ...
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality ...
Former first lady Jill Biden shared her disbelief over the White House doctors’ negligence regarding former President Joe Biden’s cancer diagnosis. In May 2025, Joe was diagnosed ...
An investigator reported 10-year follow-up data from a phase 3 trial of extended vs limited pelvic lymph node dissection during radical prostatectomy.
Former first lady Jill Biden admitted that she worried her husband Joe Biden was “having a stroke” during his ill-fated 2024 ...
Hosted on MSN
Joe Biden delivers first public remarks since prostate cancer diagnosis, says he has ‘no regrets’ about not running
Participating in a Memorial Day commemoration, Joe Biden made his first public address since the announcement of his Stage 4 prostate cancer diagnosis at a Biden family event in his home state of ...
Former President Joe Biden has filed a lawsuit against the Justice Department to prevent the release of audio from interviews ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results